department of pharmacology



Dr. Paul E. DiCorleto

Lerner Research Institute,
Cleveland Clinic
Chairman, Department of Molecular Medicine, Case School of Medicine

Dr. Paul E. DiCorleto is the Chairman of the Lerner Research Institute of the Cleveland Clinic and Chairman, Department of Molecular Medicine, Case School of Medicine. The Lerner Research Institute is home to over 130 principal investigators and 1000 employees performing biomedical research that ranges from structural biology to biomedical engineering. Over $72 million of NIH grant support will be awarded to Lerner scientists in 2004.  Dr. DiCorleto received his undergraduate training in chemistry at Rensselaer Polytechnic Institute and his doctorate in biochemistry from Cornell University.  Dr. DiCorleto’s research focuses on the molecular and cellular basis of atherosclerosis.  He has been with the Cleveland Clinic Foundation for over 20 years, having served previously as Chairman of the Department of Cell Biology, as an Associate Chief of Staff, and as a member of the Clinic’s Board of Governors and Board of Trustees.  On a national level, he has chaired multiple NIH and American Heart Association review panels, as well as several national conferences on research into heart and vascular disease.  He has published over 100 articles in his field and serves on the editorial board of multiple scientific journals.  Dr. DiCorleto has recently served as President of the North American Vascular Biology Organization, and chair of the Vascular Biology study section of the national American Heart Association, and is a member of the Association of American Medical Colleges’ Advisory Panel on Research.